Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06373094
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-18
First Post:
2024-03-19
Brief Title:
A Single Dose Escalation Study of HHT201 in Healthy Subjects
Sponsor:
Shanghai Synergy Pharmaceutical Sciences Co Ltd
Organization:
Zhejiang Huahai Pharmaceutical Co Ltd
Study Overview
Official Title:
A Single-center Open-label Single-dose Ascending Phase I Clinical Study Evaluating the Safety Tolerability and Pharmacokinetic Profile of HHT201 Donepezil Dihydroxynaphthalate for Injection in Healthy Subjects
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None